Medacta Group SA (MEDGF)
83.91
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
Medacta Group Total Liabilities (Quarterly): 404.39M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 404.39M |
| June 30, 2023 | 377.14M |
| June 30, 2023 | 377.14M |
| December 31, 2022 | 332.26M |
| June 30, 2022 | 311.93M |
| June 30, 2022 | 311.93M |
| December 31, 2021 | 297.63M |
| June 30, 2021 | 316.15M |
| Date | Value |
|---|---|
| June 30, 2021 | 316.15M |
| December 31, 2020 | 340.97M |
| June 30, 2020 | 328.88M |
| June 30, 2020 | 328.88M |
| December 31, 2019 | 324.10M |
| June 30, 2019 | 326.84M |
| June 30, 2019 | 326.84M |
| December 31, 2018 | 316.32M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
297.63M
Minimum
Dec 2021
404.39M
Maximum
Dec 2023
334.75M
Average
326.84M
Median
Jun 2019
Total Liabilities (Quarterly) Benchmarks
| AC Immune SA | 26.40M |
| CRISPR Therapeutics AG | 346.77M |
| Addex Therapeutics Ltd | 4.163M |
| NLS Pharmaceutics Ltd | 6.557M |
| Molecular Partners AG | 26.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 769.22M |
| Shareholders Equity (Quarterly) | 364.82M |
| Debt to Equity Ratio | 0.4885 |
| Current Ratio | 2.332 |
| Net Debt Paydown Yield | -3.55% |